Discussed is the value of Revlimid (lenalidomide) maintenance post-autologous stem cell transplant (as based on a recent French study).

IMWG Myeloma Experts debate the latest trends in treatment
June 9, 2016
Copenhagen, Denmark

Previous Post
7th Annual International Myeloma Working Group (IMWG) Summit a big success
Next Post
IMWG Conference Series - Copenhagen 2016: How do you use MRD testing?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.